Vis enkel innførsel

dc.contributor.authorÅm, Marte Kierulf
dc.contributor.authorTeigen, Ingrid Anna
dc.contributor.authorCarlsen, Sven Magnus
dc.contributor.authorChristiansen, Sverre Christian
dc.date.accessioned2023-05-15T13:41:05Z
dc.date.available2023-05-15T13:41:05Z
dc.date.created2023-04-11T13:19:40Z
dc.date.issued2023
dc.identifier.citationScandinavian Journal of Laboratory Animal Science (SJLAS). 2023, 49 (1), 1-5.en_US
dc.identifier.issn2002-0112
dc.identifier.urihttps://hdl.handle.net/11250/3067980
dc.description.abstractPigs are common animal models in diabetes research. Streptozotocin-induced destruction of pancreatic β-cells is used to induce diabetes in conscious pigs. However, in short-term non-recovery experiments, suppression of endogenous insulin secretion can be faster and more easily achieved with somatostatin analogues. We report a series of severe and unexpected episodes of severe bradycardia in eight pigs during non-recovery experiments with the original aim of investigating the pharmacokinetics and pharmacodynamics of intraperitoneal hormone delivery. The adverse events occurred four to five hours into the experiments, and we believe that they were caused by an interaction between the somatostatin analogue octreotide, and the sedative drug xylazine and that atropine delayed the time of occurrence.en_US
dc.description.abstractSevere bradycardia and hypotension in anaesthetized pigs: Possible interaction between octreotide, xylazine, and atropine: A case seriesen_US
dc.language.isoengen_US
dc.publisherScionicsen_US
dc.relation.urihttps://ojs.utlib.ee/index.php/SJLAS/article/view/22374/16998
dc.subjectUønskede hendelseren_US
dc.subjectUønskede hendelseren_US
dc.subjectDiabetesen_US
dc.subjectDiabetesen_US
dc.subjectForsøksdyren_US
dc.subjectAnimals Laboratoryen_US
dc.titleSevere bradycardia and hypotension in anaesthetized pigs: Possible interaction between octreotide, xylazine, and atropine: A case seriesen_US
dc.title.alternativeSevere bradycardia and hypotension in anaesthetized pigs: Possible interaction between octreotide, xylazine, and atropine: A case seriesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.subject.nsiVDP::Basale medisinske, odontologiske og veterinærmedisinske fag: 710en_US
dc.subject.nsiVDP::Basic medical, dental and veterinary sciences: 710en_US
dc.source.pagenumber1-5en_US
dc.source.volume49en_US
dc.source.journalScandinavian Journal of Laboratory Animal Science (SJLAS)en_US
dc.source.issue1en_US
dc.identifier.cristin2139980
dc.relation.projectSamarbeidsorganet mellom Helse Midt-Norge og NTNU: 2014/23166en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel